flosequinoxan has been researched along with aldosterone in 1 studies
| Studies (flosequinoxan) | Trials (flosequinoxan) | Recent Studies (post-2010) (flosequinoxan) | Studies (aldosterone) | Trials (aldosterone) | Recent Studies (post-2010) (aldosterone) |
|---|---|---|---|---|---|
| 11 | 2 | 0 | 25,333 | 1,517 | 4,169 |
| Protein | Taxonomy | flosequinoxan (IC50) | aldosterone (IC50) |
|---|---|---|---|
| Mineralocorticoid receptor | Homo sapiens (human) | 0.0048 | |
| Mineralocorticoid receptor | Rattus norvegicus (Norway rat) | 0.043 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Janssen, MC; Reyenga, J; Smits, P; Thien, T | 1 |
1 other study(ies) available for flosequinoxan and aldosterone
| Article | Year |
|---|---|
Acute effects of flosequinan (BTS 49465) in untreated moderate to severe hypertension.
Topics: Administration, Oral; Adult; Aldosterone; Epinephrine; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Quinolines; Quinolones; Renin; Vasodilator Agents | 1995 |